Increasing the number or enhancing the function of effector cells in patients has been found to bolster the tumor-fighting abilities of T and NK cell subsets.[40] In this context, we analyzed the mean values of the T cell subset (CD3+, CD3 + CD4+, CD3 + CD8+) and NK cell subset (CD3 − CD56+) ratios using available data from both the Xihuang Pills/Capsules combined with Western medicine treatment group and the Western medicine alone group. The gene discussed is NCAM1; the disease is neoplasm.